Diffuse large B-cell lymphoma

Diagnostic Histopathology

Volumn 16, Issue 2, 2010, Pages 69-81

  Gatter, Kevin ^a   Pezzella, Francesco ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

borderline categories; diffuse large B cell lymphoma; WHO classification

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BURKITT LYMPHOMA; CANCER SURVIVAL; CHRONIC INFLAMMATION; CLINICAL FEATURE; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; EPSTEIN BARR VIRUS; HEMATOPOIETIC SYSTEM TUMOR; HISTIOCYTIC LYMPHOMA; HISTIOCYTIC SARCOMA; HISTOLOGY; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOPHENOTYPING; INFECTIOUS MONONUCLEOSIS; LARGE CELL LYMPHOMA; LYMPHATIC SYSTEM TUMOR; LYMPHOCYTE PROLIFERATION; LYMPHOMA; LYMPHOMATOID GRANULOMATOSIS; PATHOLOGIST; PLASMABLASTIC LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; PROGNOSIS; SKIN LYMPHOMA; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

EID: 76449097737     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2009.12.002     Document Type: Article

References (42)

1. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. [see comments]. Blood 84 (1994) 1361-1392
2. Engelhard M., Brittinger G., Huhn D., et al. Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. Blood 89 (1997) 2291-2297
3. In: Swerdlow S.H., Campo E., Harris N.L., et al. (Eds). WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edn (2008), IARC Press, Lyon
4. Haralambieva E., Pulford K.A.F., Lamont L., et al. Anaplastic large cell lymphomas of B cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B cell lymphomas. Br J Haematol 109 (2000) 584-591
5. Dogan A., Bagdi E., Munson P., and Isaacson P.G. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol 24 (2000) 846-852
6. Weiss L., Warnke R., Sklar J., and Cleary M. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 317 (1987) 1185-1189
7. Lipford E., Wright J., Urba W., et al. Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region. Blood 70 (1987) 1816-1823
8. Ye B.H., Lista F., Lo Coco F., et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262 (1993) 747-750
9. Lo Coco F., Ye B.H., Lista F., et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 83 (1994) 1757-1759
10. Chaganti S.R., Chen W., Parsa N., et al. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma. Genes Chromosomes Cancer 23 (1998) 323-327
11. Coiffier B. Rituximab therapy in malignant lymphoma. Oncogene 26 (2007 May 28) 3603-3613
12. Dunleavy K., Staudt L.M., and Wilson W.H. The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma. Leuk Lymphoma 48 (2007 Jun) 1061-1063
13. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
14. Hans C.P., Weisenburger D.D., Greiner T.C., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (2004 Jan 1) 275-282
15. Amen F., Horncastle D., Elderfield K., et al. Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients. Histopathology 51 (2007 Jul) 70-79
16. Compagno M., Lim W.K., Grunn A., et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 459 (2009 Jun 4) 717-721
17. Dunleavy K., Pittaluga S., Czuczman M.S., et al. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood 113 (2009 Jun 11) 6069-6076
18. Achten R., Verhoef G., Vanuytsel L., and De Wolf-Peeters C. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology 40 (2002 Jan) 31-45
19. Batchelor T., and Loeffler J.S. Primary CNS lymphoma. J Clin Oncol 24 (2006 Mar 10) 1281-1288
20. Willemze R., Jaffe E.S., Burg G., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105 (2005 May 15) 3768-3785
21. Park S., Lee J., Ko Y.H., et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 110 (2007 Aug 1) 972-978
22. Oyama T., Yamamoto K., Asano N., et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 13 (2007 Sep 1) 5124-5132
23. Hummel M., Anagnostopoulos I., Korbjuhn P., and Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types. J Pathol 175 (1995 Mar) 263-271
24. Mori N., Yatabe Y., Narita M., Kobayashi T., and Asai J. Pyothorax-associated lymphoma. An unusual case with biphenotypic character of T and B cells. Am J Surg Pathol 20 (1996) 760-766
25. Gitelson E., Al-Saleem T., and Smith M.R. Review: lymphomatoid granulomatosis: challenges in diagnosis and treatment. Clin Adv Hematol Oncol 7 (2009 Jan) 68-70
26. Cazals-Hatem D., Lepage E., Brice P., et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol 20 (1996) 877-888
27. Falini B., Venturi S., Martelli M., et al. Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol 89 (1995) 780-789
28. Copie-Bergman C., Gaulard P., Maouche-Chrétien L., et al. The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood 94 (1999) 3567-3575
29. Ferreri A.J., Campo E., Ambrosetti A., et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol 15 (2004 Aug) 1215-1221
30. Ferreri A.J., Dognini G.P., Govi S., et al. Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?. J Clin Oncol 26 (2008 Nov 1) 5134-5136 author reply 6-7
31. Shimada K., Matsue K., Yamamoto K., et al. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 26 (2008 Jul 1) 3189-3195
32. Delsol G., Lamant L., Mariame B., et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood 89 (1997) 1483-1490
33. Reichard K.K., McKenna R.W., and Kroft S.H. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. Mod Pathol 20 (2007 Mar) 310-319
34. Brown R.S., Campbell C., Lishman S.C., Spittle M.F., and Miller R.F. Plasmablastic lymphoma: a new subcategory of human immunodeficiency virus-related non-Hodgkin's lymphoma. Clin Oncol 10 (1998) 327-329
35. Teruya-Feldstein J., Chiao E., Filippa D.A., et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15 (2004 Nov) 1673-1679
36. Oksenhendler E., Boulanger E., Galicier L., et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99 (2002 Apr 1) 2331-2336
37. Seliem R.M., Griffith R.C., Harris N.L., et al. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ man: the spectrum of HHV-8+ lymphoproliferative disorders expands. Am J Surg Pathol 31 (2007 Sep) 1439-1445
38. Chadburn A., Hyjek E., Mathew S., Cesarman E., Said J., and Knowles D.M. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 28 (2004 Nov) 1401-1416
39. Nador R.G., Cesarman E., Chadburn A., et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88 (1996) 645-656
40. Cesarman E., and Knowles D.M. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Semin Cancer Biol 9 (1999) 165-174
41. Traverse-Glehen A., Pittaluga S., Gaulard P., et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol 29 (2005 Nov) 1411-1421
42. Savage K.J., Monti S., Kutok J.L., et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102 (2003 Dec 1) 3871-3879